Falls Church, VA · Founded 2021 · Privately Held (backing)
Developer an intestinal microsomal triglyceride transfer protein inhibitor designed to treat the metabolic side effects of antipsychotic drugs. Response Pharmaceuticals is based in Falls Church, VA and was founded in 2021. It was valued at $30 million at its early-stage round in Nov 2025, the last priced event on record. It has raised $16.9 million across 2 recorded rounds; the latest was a $3.9 million debt round in Jun 2024.
PMV mark · valuation
$30.0M
Oct 2026
Priced at
its early-stage round
Nov 2025
Total raised
$16.9M
Last round
Debt
Jun 2024
Team — not yet on record
No current team members for Response Pharmaceuticals are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Response Pharmaceuticals with a free account
·Watch Response Pharmaceuticals: the Monday email on marks, rounds and moves
